TITLE

Shire could return £2bn to investors

AUTHOR(S)
BEN HARRINGTON
PUB. DATE
May 2013
SOURCE
Mail on Sunday;5/19/2013, p86
SOURCE TYPE
Newspaper
DOC. TYPE
Article
ABSTRACT
BRITISH drugs giant Shire is looking at ways of giving as much as £2billion back to its shareholders to bolster its defences against a possible foreign takeover bid.
ACCESSION #
87640830

 

Related Articles

  • SHARES in Shire rose 94p [...]. Rupert Steiner // Daily Mail;12/11/2014, p82 

    SHARES in Shire rose 94p to 4429p after the pharmaceutical firm used an investor day to say that a new slate of drugs - known as a pipeline - will contribute £1.8bn in product sales by 2020. Shire also announced a collaboration with Cystic Fibrosis Foundation Therapeutics. Chief executive...

  • SHARES in Shire rose 94p [...]. Rupert Steiner // Daily Mail;12/11/2014, p82 

    SHARES in Shire rose 94p to 4429p after the pharmaceutical firm used an investor day to say that a new slate of drugs - known as a pipeline - will contribute £1.8bn in product sales by 2020. Shire also announced a collaboration with Cystic Fibrosis Foundation Therapeutics. Chief executive...

  • Dragon Oil roars.  // Daily Mail;6/7/2012, p73 

    A �3BN oil explorer announced plans yesterday to buy back �130m of shares as it returns burgeoning profits to investors.

  • Loss-making Aviva eyes dividend cut. Ben Griffiths // Daily Mail;3/ 4/2013, p62 

    INSURANCE giant Aviva is set to disappoint investors this week as it slumps £3bn into the red for 2012 and could cut its dividend.

  • RBS ponders share settlement.  // Daily Mail;3/18/2014, p66 

    ROYAL Bank of Scotland could hand out shares to settle a £4bn lawsuit by disgruntled investors.

  • Pain relief. ALEX BRUMMER // Daily Mail;4/23/2014, p57 

    RECENT depression for Glaxo investors will be lifted - without having to dose up on Seroxat - by the return of £4bn of capital from the deals with Novartis.

  • Shire higher as Square Mile rethinks $32 billion Baxalta pharma deal. Jamie Nimmo // Evening Standard;1/13/2016, p39 

    INVESTORS are coming round to the $32 billion (£22 billion) bid for Baxalta by Shire, having for the past six months feared the deal could burn a hole in the Dublin-based drugmaker's pocket.

  • Shire shares soar on talk of takeovers. Peter Campbell // Daily Mail;6/21/2014, p89 

    MORE than £4bn was added to Shire's market value yesterday after the drugs maker confirmed it was a takeover target.

  • Rollercoaster ride at Shire as shares fall but brokers cheer. Laura Chesters // Evening Standard;10/26/2012, p57 

    INVESTORS in Shire are used to bumpy rides, and today was yet another one.

  • EDF forced to look for investors in power plan.  // Daily Mail;5/29/2013, p67 

    THE deal to build Britain's nuclear power stations could be delayed until the autumn as EDF sounds out external investors to back the £14bn project.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics